Gentamycin Sulphate

Producers shown on SFDA

(Record date:27/08/2021）

Producers shown on EP

Not showing any

Producer:Fuan Pharmaceutical Group Yantai Zhichu Pharmaceutical Co., Ltd. was established in 1990. It is a comprehensive pharmaceutical enterprise focusing on the production of API, western medicine preparation, natural medicine and bioengineering. In recent 20 years, the company's production and operation has achieved high-speed, stable and sustainable development.

The company covers an area of 120000 square meters, a construction area of 83000 square meters and a registered capital of 240.1601 million yuan. It is a high-tech enterprise and has obtained the import and export right of foreign trade. It is one of the backbone enterprises and major foreign exchange earning enterprises in Yantai.

The production plant is designed and constructed according to the drug production quality specifications. The equipment layout is reasonable, the process technology is advanced, the production equipment is excellent, and the detection means are perfect. The current production capacity is: an annual output of 400 tons of API, 1 billion tablets, 100 million small volume injections and 5 million lyophilized powder injections.

Registered capital:RMB 240.1601 million

Producer:Heilongjiang Greenhurst Biotechnology Co., Ltd., a wholly-owned subsidiary of Tianjin Zhongsheng Investment Co., Ltd., with a registered capital of 30 million, is located in Xingshan Park, Zhaozhou, Daqing City, Heilongjiang Province, covering an area of 180000 square meters. It is a large biopharmaceutical enterprise specializing in the R & D, production and sales of fermentation APIs. The total investment of the company is about 410 million yuan. In the first phase of 2013, the company invested 210 million yuan to build a multifunctional fermentation production line with a total tonnage of 660 cubic meters.

The plant design and equipment selection of the company meet the GMP requirements. The production workshop includes air conditioning and purification system, water preparation room, central control laboratory, mold room and seed room, with a 10000 level clean area.

Staff size:200-299 persons
Registered capital:RMB 30 million

Producer:North China Pharmaceutical Group Hualuan Co., Ltd. was completed and put into operation in September 1986. It is the largest antibiotic production base in China and the holding subsidiary of North China Pharmaceutical Group. The company covers an area of 200000 square meters, has fixed assets of 200 million yuan, and has nearly 1000 employees, of which 25% are professional technicians. It mainly produces lincomycin hydrochloride API, gentamicin sulfate API, vitamin B12 API and vitamin B12 feed additives, with a fermentation capacity of 3200 tons. The production technology level and production cost are the advanced level of the same industry in China, and the environmental protection treatment has reached the standard in 2000. The company takes "quality is always the first, human health is supreme" as its purpose, and adopts internationally advanced production equipment and technology. A sound quality assurance system ensures the full implementation of GMP. The product quality adopts international advanced quality standards. The products are exported to Europe, the United States and other places, and the export volume accounts for 80% of the total output.

Staff size:50-99 persons
Registered capital:RMB 11.46 million

Producer:Fujian Fukang Pharmaceutical Co., Ltd (Fukang) is located in Fuzhou-capital of Fujian province, founded in 1958, renamed Fuzhou Antibiotic General Factory in 1992 and became a wholly state-owned enterprise in 1996. In 2002 it was reformed into a corporation with a variety of shareholders. Over more than 40 years Fukang is steadily growing. Starting from a single product, its current product range includes 7ACA intermediate, sterile cephalosporin API, antibiotic API, preparation and Animal Feed. As one of the top 100 pharmaceutical enterprises in China in terms of sales volume and profit, Fukang has successfully established and maintained a long-term and sound business relationship with more than 100 companies over the world. Following the sustained .

Staff size:100-199 persons

Registered capital:RMB 207 million 929 thousand and 849

Producer:Founded in 1968, Sichuan Long March Pharmaceutical Co., Ltd. is located in Leshan City, a famous historical and cultural city in Southwest Sichuan Province. Long March, directly controlled by Sichuan Lanyan Investment Group Co., Ltd. (hereinafter referred to Lanyan Group), is a large antibiotic API production enterprise in Southwest China, which is the core enterprise of key medical pharmaceutical industry of Lanyan Group.

With more than 50 years’ experience in production and operation since its establishment, Long March has been in strict accordance with the national industrial policy and the production and operation regulations of the pharmaceutical industry, adhering to the business philosophy of responsibility, quality, integrity and innovation, taking the construction of modern medical and pharmaceutical enterprise as the development goal, and constantly growing and developing. The company's business scope covers biological fermentation, chemical synthesis, pharmaceutical machinery and other fields, with more than 100 products. The main API products are sold to 63 countries and regions such as the United States, Europe, Japan, Australia, Africa and Southeast Asia. The CY and Shanjiang trademarks are well-known at home and abroad. The company has multiple production lines which have passed the GMP certification inspection in China. In 1982, the company took the lead in China and passed the FDA certification inspection for 14 consecutive times. Eight products were approved to enter the U.S. market successively. At the same time, it took the lead in successfully registering in the European Union in 2002 and passed the EDQM certification inspection for three times in a row. 

Staff size:400-499 persons

Registered capital:RMB 128.22 million

Producer:Jiangxi Pharmaceutical Co., Ltd. (Jiangxi pharmaceutical factory), founded in March 1950, is now located at No. 758, Huiren West Avenue, Xiaolan Industrial Park, Nanchang. It covers an area of 300 mu and has a registered capital of 295.8 million yuan.

After more than 60 years of development, the company has strong technical force and sophisticated pharmaceutical equipment. It carries out production and product quality inspection and monitoring in strict accordance with the requirements of national GMP standards, and has advanced pharmaceutical equipment and testing instruments. Small volume injection workshop, large volume injection workshop, solid oral preparation workshop and API workshop have all passed GMP certification.   The company has an annual production capacity of 300 million injections, 2 billion tablets, 100 million capsules, 20 million bottles of infusion and 800 cubic meters of antibiotic fermentation. 343 preparations have obtained the national drug production approval number.

Staff size:300-399 persons

Registered capital:RMB 295.8 million